📊 TDOC Key Takeaways
Is Teladoc Health, Inc. (TDOC) a Good Investment?
Teladoc is structurally unprofitable with a critically weak 3.3% gross margin and -10.4% operating margin on $2.5B in revenue, coupled with declining revenue (-1.5% YoY). While a strong balance sheet ($781M cash, 0.03x D/E) provides a financial runway, the persistent inability to achieve profitability or positive returns on capital (ROE -14.5%, ROA -7.0%) indicates fundamental business model challenges that threaten long-term sustainability.
Why Buy Teladoc Health, Inc. Stock? TDOC Key Strengths
- Strong balance sheet with $781.1M cash and minimal long-term debt ($42.4M), providing financial flexibility
- Healthy liquidity position (2.77x current ratio) reduces bankruptcy risk in the near term
- Positive free cash flow of $285.5M despite GAAP losses demonstrates some cash generation capability
TDOC Stock Risks: Teladoc Health, Inc. Investment Risks
- Significant operating loss of $263M and net loss of $200.3M on $2.5B revenue indicates fundamental unprofitability
- Critically low gross margin of 3.3% combined with negative operating margin of -10.4% reflects severe operational inefficiency
- Declining revenue (-1.5% YoY) paired with persistent losses raises questions about business model viability and competitive positioning
- Negative returns on capital (ROE -14.5%, ROA -7.0%) indicate shareholder value destruction and poor capital deployment
- Large divergence between positive FCF and negative net income suggests non-sustainable cash generation or significant non-cash charges
Key Metrics to Watch
- Gross margin trajectory - must expand materially to reach operational profitability
- Revenue growth rate - current decline must stabilize and turn positive
- Operating margin path to profitability - monitor quarterly improvement toward breakeven
- Operating cash flow sustainability - verify ongoing cash generation is not driven by working capital swings
- Operating leverage metrics - analyze revenue per employee and unit economics
Teladoc Health, Inc. (TDOC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.77x current ratio provides a solid financial cushion.
TDOC Profit Margin, ROE & Profitability Analysis
TDOC vs Services Sector: How Teladoc Health, Inc. Compares
How Teladoc Health, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Teladoc Health, Inc. Stock Overvalued? TDOC Valuation Analysis 2026
Based on fundamental analysis, Teladoc Health, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Teladoc Health, Inc. Balance Sheet: TDOC Debt, Cash & Liquidity
TDOC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Teladoc Health, Inc.'s revenue has shown modest growth of 8% over the 5-year period. The most recent EPS of $-1.34 indicates the company is currently unprofitable.
TDOC Revenue Growth, EPS Growth & YoY Performance
TDOC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $626.4M | -$33.3M | $-0.19 |
| Q2 2025 | $631.9M | -$32.7M | $-0.19 |
| Q1 2025 | $629.4M | -$81.9M | $-0.49 |
| Q3 2024 | $640.5M | -$33.3M | $-0.19 |
| Q2 2024 | $642.4M | -$65.2M | $-0.40 |
| Q1 2024 | $629.2M | -$69.2M | $-0.42 |
| Q3 2023 | $611.4M | -$57.1M | $-0.35 |
| Q2 2023 | $592.4M | -$65.2M | $-0.40 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Teladoc Health, Inc. Dividends, Buybacks & Capital Allocation
TDOC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Teladoc Health, Inc. (CIK: 0001477449)
📋 Recent SEC Filings
❓ Frequently Asked Questions about TDOC
What is the AI rating for TDOC?
Teladoc Health, Inc. (TDOC) has an AI rating of SELL with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are TDOC's key strengths?
Claude: Strong balance sheet with $781.1M cash and minimal long-term debt ($42.4M), providing financial flexibility. Healthy liquidity position (2.77x current ratio) reduces bankruptcy risk in the near term.
What are the risks of investing in TDOC?
Claude: Significant operating loss of $263M and net loss of $200.3M on $2.5B revenue indicates fundamental unprofitability. Critically low gross margin of 3.3% combined with negative operating margin of -10.4% reflects severe operational inefficiency.
What is TDOC's revenue and growth?
Teladoc Health, Inc. reported revenue of $2.5B.
Does TDOC pay dividends?
Teladoc Health, Inc. does not currently pay dividends.
Where can I find TDOC SEC filings?
Official SEC filings for Teladoc Health, Inc. (CIK: 0001477449) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is TDOC's EPS?
Teladoc Health, Inc. has a diluted EPS of $-1.14.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is TDOC a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Teladoc Health, Inc. has a SELL rating with 78% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is TDOC stock overvalued or undervalued?
Valuation metrics for TDOC: ROE of -14.5% (sector avg: 16%), net margin of -7.9% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy TDOC stock in 2026?
Our dual AI analysis gives Teladoc Health, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is TDOC's free cash flow?
Teladoc Health, Inc.'s operating cash flow is $294.4M, with capital expenditures of $8.9M. FCF margin is 11.3%.
How does TDOC compare to other Services stocks?
Vs Services sector averages: Net margin -7.9% (avg: 10%), ROE -14.5% (avg: 16%), current ratio 2.77 (avg: 1.5).